507 related articles for article (PubMed ID: 14722300)
1. CD81 is required for hepatitis C virus glycoprotein-mediated viral infection.
Zhang J; Randall G; Higginbottom A; Monk P; Rice CM; McKeating JA
J Virol; 2004 Feb; 78(3):1448-55. PubMed ID: 14722300
[TBL] [Abstract][Full Text] [Related]
2. Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner.
McKeating JA; Zhang LQ; Logvinoff C; Flint M; Zhang J; Yu J; Butera D; Ho DD; Dustin LB; Rice CM; Balfe P
J Virol; 2004 Aug; 78(16):8496-505. PubMed ID: 15280458
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles.
Hsu M; Zhang J; Flint M; Logvinoff C; Cheng-Mayer C; Rice CM; McKeating JA
Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7271-6. PubMed ID: 12761383
[TBL] [Abstract][Full Text] [Related]
4. Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection.
Meola A; Sbardellati A; Bruni Ercole B; Cerretani M; Pezzanera M; Ceccacci A; Vitelli A; Levy S; Nicosia A; Traboni C; McKeating J; Scarselli E
J Virol; 2000 Jul; 74(13):5933-8. PubMed ID: 10846074
[TBL] [Abstract][Full Text] [Related]
5. CD81 Receptor Regions outside the Large Extracellular Loop Determine Hepatitis C Virus Entry into Hepatoma Cells.
Banse P; Moeller R; Bruening J; Lasswitz L; Kahl S; Khan AG; Marcotrigiano J; Pietschmann T; Gerold G
Viruses; 2018 Apr; 10(4):. PubMed ID: 29677132
[TBL] [Abstract][Full Text] [Related]
6. Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor.
Bartosch B; Vitelli A; Granier C; Goujon C; Dubuisson J; Pascale S; Scarselli E; Cortese R; Nicosia A; Cosset FL
J Biol Chem; 2003 Oct; 278(43):41624-30. PubMed ID: 12913001
[TBL] [Abstract][Full Text] [Related]
7. CD81 is an entry coreceptor for hepatitis C virus.
Cormier EG; Tsamis F; Kajumo F; Durso RJ; Gardner JP; Dragic T
Proc Natl Acad Sci U S A; 2004 May; 101(19):7270-4. PubMed ID: 15123813
[TBL] [Abstract][Full Text] [Related]
8. Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: putative CD81 binding region 1 is not involved in CD81 binding.
Rothwangl KB; Manicassamy B; Uprichard SL; Rong L
Virol J; 2008 Mar; 5():46. PubMed ID: 18355410
[TBL] [Abstract][Full Text] [Related]
9. Primary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infection.
Zhao X; Tang ZY; Klumpp B; Wolff-Vorbeck G; Barth H; Levy S; von Weizsäcker F; Blum HE; Baumert TF
J Clin Invest; 2002 Jan; 109(2):221-32. PubMed ID: 11805134
[TBL] [Abstract][Full Text] [Related]
10. Entry of hepatitis C virus pseudotypes into primary human hepatocytes by clathrin-dependent endocytosis.
Codran A; Royer C; Jaeck D; Bastien-Valle M; Baumert TF; Kieny MP; Pereira CA; Martin JP
J Gen Virol; 2006 Sep; 87(Pt 9):2583-2593. PubMed ID: 16894197
[TBL] [Abstract][Full Text] [Related]
11. Diverse CD81 proteins support hepatitis C virus infection.
Flint M; von Hahn T; Zhang J; Farquhar M; Jones CT; Balfe P; Rice CM; McKeating JA
J Virol; 2006 Nov; 80(22):11331-42. PubMed ID: 16943299
[TBL] [Abstract][Full Text] [Related]
12. The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells.
Koutsoudakis G; Herrmann E; Kallis S; Bartenschlager R; Pietschmann T
J Virol; 2007 Jan; 81(2):588-98. PubMed ID: 17079281
[TBL] [Abstract][Full Text] [Related]
13. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes.
Bartosch B; Dubuisson J; Cosset FL
J Exp Med; 2003 Mar; 197(5):633-42. PubMed ID: 12615904
[TBL] [Abstract][Full Text] [Related]
14. Binding of hepatitis C virus to CD81.
Pileri P; Uematsu Y; Campagnoli S; Galli G; Falugi F; Petracca R; Weiner AJ; Houghton M; Rosa D; Grandi G; Abrignani S
Science; 1998 Oct; 282(5390):938-41. PubMed ID: 9794763
[TBL] [Abstract][Full Text] [Related]
15. The small extracellular loop of CD81 is necessary for optimal surface expression of the large loop, a putative HCV receptor.
Masciopinto F; Campagnoli S; Abrignani S; Uematsu Y; Pileri P
Virus Res; 2001 Nov; 80(1-2):1-10. PubMed ID: 11597743
[TBL] [Abstract][Full Text] [Related]
16. Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor.
Wünschmann S; Medh JD; Klinzmann D; Schmidt WN; Stapleton JT
J Virol; 2000 Nov; 74(21):10055-62. PubMed ID: 11024134
[TBL] [Abstract][Full Text] [Related]
17. Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus.
Lavillette D; Tarr AW; Voisset C; Donot P; Bartosch B; Bain C; Patel AH; Dubuisson J; Ball JK; Cosset FL
Hepatology; 2005 Feb; 41(2):265-74. PubMed ID: 15660396
[TBL] [Abstract][Full Text] [Related]
18. Characterization of pseudotype VSV possessing HCV envelope proteins.
Matsuura Y; Tani H; Suzuki K; Kimura-Someya T; Suzuki R; Aizaki H; Ishii K; Moriishi K; Robison CS; Whitt MA; Miyamura T
Virology; 2001 Aug; 286(2):263-75. PubMed ID: 11485395
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus entry: potential receptors and their biological functions.
Cocquerel L; Voisset C; Dubuisson J
J Gen Virol; 2006 May; 87(Pt 5):1075-1084. PubMed ID: 16603507
[TBL] [Abstract][Full Text] [Related]
20. Binding of hepatitis C virus-like particles derived from infectious clone H77C to defined human cell lines.
Wellnitz S; Klumpp B; Barth H; Ito S; Depla E; Dubuisson J; Blum HE; Baumert TF
J Virol; 2002 Feb; 76(3):1181-93. PubMed ID: 11773394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]